The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

The funds will be used for general corporate purposes, with a focus on reducing operating expenses and exploring strategic alternatives for MAT2203, the Company’s Phase 3-ready antifungal drug ...

Multidrug resistance in the pathogenic fungus Candida glabrata is a growing global threat. Here, the authors show that a mutation in gene IPI1, involved in pre-rRNA processing, leads to multidrug ...

Background: Cryptococcal meningitis (CM) is a significant global health issue ... offering new hope for treating CM and other refractory fungal infections of the central nervous system. We used the ...